A Brief Review of Diagnosis of Small Ruminants Brucellosis

doi:10.2174/0929867328666201231121226

摘要

由布鲁氏菌属细菌引起的布鲁氏菌病仍然是世界上的一种主要的人畜共患病病，是一种对畜牧业和公共卫生产生严重经济影响的传染病。布鲁氏菌属有10种，最普遍的是黑氏布鲁氏菌。反刍动物布鲁氏菌病的诊断是基于细菌学和免疫学试验。疫苗的使用和由其他交叉反应细菌引起的假阳性血清学反应(FPSR)代表了免疫学背景。这一复杂的背景导致了大量诊断布鲁氏菌布鲁氏菌病的发展。本文的目的是简要回顾检测方法，并比较不同测试的优越性。

关键词: 布鲁氏菌病，诊断方法，小反刍动物，猪布鲁氏菌，黑氏布鲁氏菌，DNA检测系统。

« Previous Next »

Rights & Permissions Print Cite

Current Medicinal Chemistry

Title:A Brief Review of Diagnosis of Small Ruminants Brucellosis

Volume: 28 Issue: 22

关键词: 布鲁氏菌病，诊断方法，小反刍动物，猪布鲁氏菌，黑氏布鲁氏菌，DNA检测系统。

摘要: Brucellosis caused by bacteria of the genus of Brucella remains a major zoonosis in the wide world, which is an infectious disease with a severe economic impact on animal husbandry and public health. The genus of Brucella includes ten species and the most prevalent is Brucella melitensis. The diagnosis of Brucella melitensis ruminant brucellosis is based on bacteriological and immunological tests. The use of vaccines and the false-positive serological reactions (FPSR) caused by other cross-reacting bacteria represent the immunological contexts. This complex context results in the development of the large number of diagnosis of Brucella melitensis brucellosis. The aim of this article is to briefly review the detection methods and compare the superiorities of different tests.

Export Options

Export File:

RIS (for EndNote, Reference Manager, ProCite)

BibTeX

Text

Content:

Citation Only

Citation and Abstract

About this article

Cite this article as:

A Brief Review of Diagnosis of Small Ruminants Brucellosis, Current Medicinal Chemistry 2021; 28 (22) . https://dx.doi.org/10.2174/0929867328666201231121226

DOI https://dx.doi.org/10.2174/0929867328666201231121226	Print ISSN 0929-8673
Publisher Name Bentham Science Publisher	Online ISSN 1875-533X

About this journal

Call for Papers in Thematic Issues

Submission closes on : 31 December, 2024

Advances in Medicinal Chemistry: From Cancer to Chronic Diseases.

The broad spectrum of the issue will provide a comprehensive overview of emerging trends, novel therapeutic interventions, and translational insights that impact modern medicine. The primary focus will be diseases of global concern, including cancer, chronic pain, metabolic disorders, and autoimmune conditions, providing a broad overview of the advancements in ...read more

Guest Editor(s): Dr. Geir Bjørklund

Submission closes on : 31 December, 2024

Approaches to the treatment of chronic inflammation

Chronic inflammation is a hallmark of numerous diseases, significantly impacting global health. Although chronic inflammation is a hot topic, not much has been written about approaches to its treatment. This thematic issue aims to showcase the latest advancements in chronic inflammation treatment and foster discussion on future directions in this ...read more

Guest Editor(s): Dr. Vladimir Rogovskii

Submission closes on : 10 November, 2024

Cellular and Molecular Mechanisms of Non-Infectious Inflammatory Diseases: Focus on Clinical Implications

The Special Issue covers the results of the studies on cellular and molecular mechanisms of non-infectious inflammatory diseases, in particular, autoimmune rheumatic diseases, atherosclerotic cardiovascular disease and other age-related disorders such as type II diabetes, cancer, neurodegenerative disorders, etc. Review and research articles as well as methodology papers that summarize ...read more

Guest Editor(s): Dr. Igor A. Sobenin

Submission closes on : 30 September, 2024

Chalcogen-modified nucleic acid analogues

Chalcogen-modified nucleosides, nucleotides and oligonucleotides have been of great interest to scientific research for many years. The replacement of oxygen in the nucleobase, sugar or phosphate backbone by chalcogen atoms (sulfur, selenium, tellurium) gives these biomolecules unique properties resulting from their altered physical and chemical properties. The continuing interest in ...read more

Guest Editor(s): Dr. Katarzyna Kulik